Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: A novel mechanism for activation of p38

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1158-1167

  Johnson, Robert A ^a,b   Huong, Shu Mei ^b   Huang, Eng Shang ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME ACTIVATION; HEAT-SHOCK PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MAP KINASE KINASE 3; MAP KINASE KINASE 4; MAP KINASE KINASE 6; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0033977267     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1158-1167.2000     Document Type: Article

References (59)

1. Allan-Yorke, J., M. Record, C. de Preval, C. Davrinche, and J. L. Davignon. 1998. Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. J. Virol. 72:2316-2322.
2. Andrisani, O. M. 1999. CREB-mediated transcriptional control. Crit. Rev. Eukaryotic Gene Expr. 9:19-32.
3. Boyle, K. A., R. L. Pietropaolo, and T. Campton. 1999. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:3607-3613.
4. Brehm, A., E. A. Miska, D. J. McCance, J. I. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (London) 391:597-601.
5. Bresnahan, W. A., I. Boldogh, E. A. Thompson, and T. Albrecht. 1996. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150-160.
6. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
7. Chau, N. H., C. D. Vanson, and J. A. Kerry. 1999. Transcriptional regulation of the human cytomegalovirus US11 early gene. J. Virol. 73:863-870.
8. Ciocca, D. R., S. Oesterreich, G. C. Chamness, W. L. McGuire, and S. A. Fuqua. 1993. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J. Natl. Cancer Inst. 85:1558-1570.
9. Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAPK kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
10. Dhanasekaran, N., and E. P. Reddy. 1998. Signaling by dual specificity kinases. Oncogene 17:1447-1455.
11. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, and J. M. Trzaskos. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632.
12. Field, A. K., and K. K. Biron. 1 995. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7:1-13.
13. Freshney, N. W., L. Rawtinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan, and J. Saklatvala. 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039-1049.
14. Georgopoulos, C., and W. J. Welch. 1993. Role of the major heat shock proteins as molecular chaperones. Cell Biol. 9:601-634.
15. Hagemeier, C., R. Caswell, G. Hayhurst, J. H. Sinclair, and T. Kouzarides. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:2897-2903.
16. Haneda, M., T. Sugimoto, and R. Kikkawa. 1999. Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur. J. Pharmacol. 15:1-7.
17. Huang, E.-S., and T. F. Kowalik. 1993. The pathogenicity of human cytomegalovirus: an overview, p. 1-45. In Y. Becker, G. Darai, and E. S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, Berlin, Germany.
18. Huang, S., Y. Jiang, Z. Li, E. Nishida, P. Mathias, S. Lin, R. J. Ulevitch, G. R. Nemerow, and J. Han. 1997. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAPK kinase kinase 6b. Immunity 6:739-749.
19. Johnson, R. A., S. Huong, and E. Huang. 1999. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)l H-imidazoie on HCMV DNA replication and permissive infection. Antiviral Res. 41:101-111.
20. Kerry, J. A., M. A. Priddy, T. L. Staley, T. R. Jones, and R. M. Stenberg. 1997. The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. J. Virol. 71:2120-2126.
21. Kerry, J. A., M. A. Priddy, and R. M. Stenberg. 1994. Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products. J. Virol. 68:4167-4176.
22. Kowalik, T. F., B. Wing, J. S. Haskill, J. C. Azizkhan, A. S. Baldwin, Jr., and E.-S. Huang. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 90:1107-1111.
23. Larminie, C. G., H. M. Alzuherri, C. A. Cairns, A. McLees, and R. J. White. 1998. Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein. J. Mol. Med. 76:94-103.
24. Larminie, C. G., C. A. Cairns, R. Mital, T. Kouzarides, S. P. Jackson, and R. J. White. 1997. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16:2061-2071.
25. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK pathway. J. Biol. Chem. 271:20608-20616.
26. Lee, J. C., and J. L. Adams. 1995. Inhibitors of serine/threonine kinases. Curr. Opin. Biotechnol. 6:657-661.
27. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Keys, S. W. Landvattert, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (London) 372:739-746.
28. Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:74-139.
29. Lin, A., A. Minden, H. Martinetto, F.-X. Claret, C. Lang-Carter, F. Mercurio, G. L. Johnson, and M. Karin. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38 MPK. Science 268:286-290.
30. Liu, B., and M. F. Stinski. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
31. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998 Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
32. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Loran, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature (London) 391:601-605.
33. Mar, E.-C., Y.-C. Cheng, and E.-S. Huang. 1983. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro. Antimicrob. Agents Chemother. 24:518-521.
34. McLean, T. I., and S. L. Bachenheimer. 1999. Activation of c-Jun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J. Virol. 73:8415-8426.
35. Meriin, A. B., J. A. Yaglom, V. L. Gabai, D. D. Mosser, L. Zon, and M. Y. Sherman. 1999. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol. Cell. Biol. 19:2547-2555.
36. Michelson, S., P. Turowski, L. Picard, J. Goris, M. P. Landini, A. Topilko, B. Hemmings, C. Bessia, A. Garcia, and J. L. Virelizier. 1996. Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J. Virol. 70:1415-1423.
37. Mills, J., M. A. Jacombson, J. J. O'Donnell, D. Cederberg, and G. N. Holland. 1988. Treatment of cytomegalovirus retinitis in patients with AIDS. Rev. Infect. Dis. 10(Suppl.):S522-S531.
38. Minden, A, and M. Karin. 1997. Regulation and function of the JNK subgroup of MAPK kinases. Biochim. Biophys. Acta 1333:F85-F104.
39. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593.
40. Oberg, B., S. Behrnetz, B. Eriksson, H. Jozwiak, A. Larsson, J. D. Lernestedt, and V. L. Aberg. 1988. Clinical use of Foscarnet (phosphonoformate), p. 223-240. In E. D. Clercq (ed.), Clinical use of antiviral drugs. Martinus Nijhoff, Boston, Mass.
41. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
42. Popik, W., and P. M. Pitha. 1998. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p3K mitogen activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Virology 252:210-217.
43. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420-7426.
44. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davls. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
45. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180-186.
46. Rodems, S. M., and D. H. Spector. 1998. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J. Virol. 72:9173-9180.
47. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
48. Shapiro, L., K. A. Heidenreich, M. D. Meintzer, and C. A. Dinarello. 1998. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95:7422-7426.
49. Thomson, S., L. C. Mahadevan, and A. L. Clayton. 1999. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin. Cell. Dev. Biol. 10:205-214.
50. Wang, S., N. Nath, A. Minden, and S. Chellappan. 1999. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 18:1559-1570.
51. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
52. Weitzman, J. B., and M. Yaniv. 1998. Signal transduction pathways and modulation of gene activity. Clin. Chem. Lab. Med. 36:535-539.
53. Weller, T. H. 1971. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. N. Engl. J. Med. 285:203-214.
54. Yang, S. I., R. L. Lickteig, R. Estes, K. Rundell, G. Walter, and M. C. Mumby. 1991. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 11:1988-1995.
55. Yurochko, A. D., and E.-S. Huang. 1999. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162:4806-4816.
56. Yurochko, A. D., E.-S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E.-S. Huang. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71:5051-5059.
57. Yurochko, A. D., T. F. Kowalik, S.-M. Huong, and E.-S. Huang. 1995. HCMV upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
58. Yurochko, A. D., M. W. Mayo, E. E. Poma, A. S. Baldwin, Jr., and E.-S. Huang. 1997. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J. Virol. 71:4638-4648.
59. Zachos, G., B. Clements, and J. Conner. 1999. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 274:5097-5103.